| Catalog No. | HB996046 |
| Brand | abinScience |
| Species reactivity | Human |
| Form | Liquid |
| Storage buffer | 30 mM Histidine, pH5.8, 10% sucrose, 0.02% Tween80 |
| Purity | >95% purity as determined by SDS-PAGE. |
| Isotype | (scFv-kappa-heavy)-(scFv-heavy-kappa) |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Target | CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain |
| Purification | Purified by Nickel column. |
| Endotoxin level | < 10 EU/mg |
| Expression system | Mammalian cells |
| Accession | P15391 & P07766 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternative name | Bispecific, CD19, AMG103, BITEMT-103, MEDI-538, MT103, bscCD19xCD3, 853426-35-4 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype Control | BiTE Format Isotype Control for Bispecific Reference Antibody (HP473013) |
Anti-Human CD19 & CD3 epsilon Bispecific Reference Antibody (Blinatumomab, RUO)
Overview
Images
 SDS-PAGE |
SDS-PAGE for Anti-Human CD19 & CD3 epsilon Bispecific Reference Antibody (Blinatumomab, RUO) |
 Bioactivity |
SEC-HPLC detection for Research Grade Blinatumomab. |